Holen Sie sich die Stockscreener-App
3.115
2.20%
-0.065
Schlusskurs vom Vortag:
$3.18
Offen:
$3.11
24-Stunden-Volumen:
31,843
Relative Volume:
0.93
Marktkapitalisierung:
$26.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.24M
KGV:
-1.9968
EPS:
-1.56
Netto-Cashflow:
$-16.44M
1W Leistung:
-11.14%
1M Leistung:
-15.95%
6M Leistung:
-23.92%
1J Leistung:
+19.62%
1-Tages-Spanne:
$2.9101
$3.20
1-Wochen-Bereich:
$2.8205
$3.44
52-Wochen-Spanne:
$2.4377
$6.1568
Marker Therapeutics Inc Stock (MRKR) Company Profile
Firmenname
Marker Therapeutics Inc
Sektor
Branche
Telefon
(713) 400-6400
Adresse
2450 HOLCOMBE BLVD, HOUSTON, TX
Vergleichen Sie MRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MRKR | 3.14 | 26.77M | 0 | -8.24M | -16.44M | -1.56 |
| VRTX | 449.99 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 593.04 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.22 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-25 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-03-01 | Eingeleitet | Janney | Buy |
| 2018-12-03 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten
Hematopoietic Stem Cell Transplantation Market to Exhibit - openPR
Silence Therapeutics' Zerlasiran Shows 90% Reduction in Key Heart Disease Marker | SLN Stock News - StockTitan
Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Precision Optics Receives Initial Production Order for Single-Use Ophthalmic Program - The Manila Times
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
Marker Therapeutics Secures $4M NIH Grants, Reports Promising MT-601 Trial Progress | MRKR Stock News - StockTitan
Marker Therapeutics Inc (MRKR) Quarterly 10-Q Report - Quartz
Alterity's Advanced Brain Imaging Breakthrough Reveals New MSA Disease Progression Marker | ATHE Stock News - StockTitan
Dr Truong on the Background of the ImmunoCobiVem Trial in BRAF V600+ Melanoma - OncLive
MAGEA4 Opens the Door for Engineered Cellular Therapies in Solid Tumors - OncLive
US Penny Stocks To Consider In October 2024 - Simply Wall St
Allogeneic Hematopoietic Stem Cell Transplant Market to - GlobeNewswire
Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight - India Shorts
Kids Marker Market to hit USD 257.4 million by 2032, says Global Market Insights Inc. - Yahoo Finance
PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - PR Newswire UK
Omega Therapeutics stock hits 52-week low at $1.2 - Investing.com
AML cell therapy trials to watch in 2024 targeting GvHD - Yahoo Finance
Markforged (NYSE:MKFG) Sees Unusually-High Trading Volume - Defense World
Top 3 Health Care Stocks That May Explode This Month - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines
On Tuesday’s show: Medical 'Blind Spots' - WJCT NEWS
ProShare Advisors LLC Has $47.68 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna - PR Newswire
ProShare Advisors LLC Sells 43,073 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
AI Is Poised to Influence Several Areas of Cancer Care With Some Fine-Tuning - OncLive
Meiji Yasuda Asset Management Co Ltd. Has $580,000 Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Washington Journal: Dr. Marty Makary Discusses His Book "Blind Spots" & Health Care in the U.S. - C-SPAN
Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hematopoietic Stem Cell Transplantation Global Market Report 2024 Size and Forecast - WhaTech
Edgestream Partners L.P. Invests $1.67 Million in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Moderna Inc [NASDAQ: MRNA] Sees Decrease in Stock Value - Knox Daily
Hematopoietic stem cell transplantation (HSCT) Market to See - openPR
Down 13% in 1 Day, Is Moderna Stock in Trouble? - The Motley Fool
Quest Partners LLC Trims Stock Position in Marsh & McLennan Companies, Inc. (NYSE:MMC) - MarketBeat
Moderna Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Parallel Advisors LLC Reduces Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
Dr. Marty Makary Talks "Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health" - The Clay Travis & Buck Sexton Show
Acadian Asset Management LLC Purchases New Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Dai ichi Life Insurance Company Ltd Boosts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World
AMG 193 Shows Preliminary Clinical Activity in MTAP-Deleted Solid Tumors - OncLive
Wedbush Securities Inc. Invests $393,000 in First Trust NASDAQ BuyWrite Income ETF (NASDAQ:FTQI) - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Recommendation of “Buy” from Analysts - Defense World
United Parks & Resorts Inc. (NYSE:PRKS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
VYNE Therapeutics Announces Positive Phase 1a SAD Data for VYN202, a Novel BD2-Selective BET Inhibitor - StockTitan
Palisade Bio Reports Data Demonstrating PDE4B Expression in - GlobeNewswire
Short Interest in Solventum Co. (NYSE:SOLV) Drops By 17.8% - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Short Interest Down 17.3% in August - Defense World
MYR Group Inc. (NASDAQ:MYRG) Short Interest Update - Defense World
Phillips 66 (NYSE:PSX) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Bank of New York Mellon Corp Acquires 36,810 Shares of SEI Investments (NASDAQ:SEIC) - Defense World
Anthem Blue Cross and Blue Shield unveils a new historic marker in Columbus - Yahoo Finance
Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):